5 bad ASX IPOs that we think will bounce back…eventually
Yesterday we looked at bad ASX IPOs (and some foreign ones too) that bounced back. The lesson we hoped investors…
Read More
Atriva Therapeutics – a new take on influenza antivirals
In September 2023 a privately held German drug development company called Atriva Therapeutics announced that it was going to go…
Read More
Will Rio Tinto’s Sharеs Skyrockеt in 2024 On The Back Of Rising Commodity Pricеs?
Rio Tinto Ltd (ASX: RIO) has еxpеriеncеd a rollеr-coastеr ridе in its share price ovеr thе past yеar duе dynamic…
Read More